266 related articles for article (PubMed ID: 19176396)
1. Prediction of clinical outcome in multiple lung cancer cohorts by integrative genomics: implications for chemotherapy selection.
Broët P; Camilleri-Broët S; Zhang S; Alifano M; Bangarusamy D; Battistella M; Wu Y; Tuefferd M; Régnard JF; Lim E; Tan P; Miller LD
Cancer Res; 2009 Feb; 69(3):1055-62. PubMed ID: 19176396
[TBL] [Abstract][Full Text] [Related]
2. Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.
Raponi M; Zhang Y; Yu J; Chen G; Lee G; Taylor JM; Macdonald J; Thomas D; Moskaluk C; Wang Y; Beer DG
Cancer Res; 2006 Aug; 66(15):7466-72. PubMed ID: 16885343
[TBL] [Abstract][Full Text] [Related]
3. An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Roepman P; Jassem J; Smit EF; Muley T; Niklinski J; van de Velde T; Witteveen AT; Rzyman W; Floore A; Burgers S; Giaccone G; Meister M; Dienemann H; Skrzypski M; Kozlowski M; Mooi WJ; van Zandwijk N
Clin Cancer Res; 2009 Jan; 15(1):284-90. PubMed ID: 19118056
[TBL] [Abstract][Full Text] [Related]
4. Relapse-related molecular signature in lung adenocarcinomas identifies patients with dismal prognosis.
Tomida S; Takeuchi T; Shimada Y; Arima C; Matsuo K; Mitsudomi T; Yatabe Y; Takahashi T
J Clin Oncol; 2009 Jun; 27(17):2793-9. PubMed ID: 19414676
[TBL] [Abstract][Full Text] [Related]
5. Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.
Lee ES; Son DS; Kim SH; Lee J; Jo J; Han J; Kim H; Lee HJ; Choi HY; Jung Y; Park M; Lim YS; Kim K; Shim Y; Kim BC; Lee K; Huh N; Ko C; Park K; Lee JW; Choi YS; Kim J
Clin Cancer Res; 2008 Nov; 14(22):7397-404. PubMed ID: 19010856
[TBL] [Abstract][Full Text] [Related]
6. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
[TBL] [Abstract][Full Text] [Related]
7. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
[TBL] [Abstract][Full Text] [Related]
8. Prediction of lymph node metastasis by analysis of gene expression profiles in non-small cell lung cancer.
Takada M; Tada M; Tamoto E; Kawakami A; Murakawa K; Shindoh G; Teramoto K; Matsunaga A; Komuro K; Kanai M; Fujiwara Y; Shirata K; Nishimura N; Miyamoto M; Okushiba S; Kondo S; Hamada J; Katoh H; Yoshiki T; Moriuchi T
J Surg Res; 2004 Nov; 122(1):61-9. PubMed ID: 15522316
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.
Hayes DN; Monti S; Parmigiani G; Gilks CB; Naoki K; Bhattacharjee A; Socinski MA; Perou C; Meyerson M
J Clin Oncol; 2006 Nov; 24(31):5079-90. PubMed ID: 17075127
[TBL] [Abstract][Full Text] [Related]
10. A prognostic test for adenocarcinoma of the lung from gene expression profiling data.
Gordon GJ; Richards WG; Sugarbaker DJ; Jaklitsch MT; Bueno R
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):905-10. PubMed ID: 14504202
[TBL] [Abstract][Full Text] [Related]
11. A five-gene signature and clinical outcome in non-small-cell lung cancer.
Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA signature predicts survival and relapse in lung cancer.
Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
[TBL] [Abstract][Full Text] [Related]
13. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal aberrations and gene expression profiles in non-small cell lung cancer.
Dehan E; Ben-Dor A; Liao W; Lipson D; Frimer H; Rienstein S; Simansky D; Krupsky M; Yaron P; Friedman E; Rechavi G; Perlman M; Aviram-Goldring A; Izraeli S; Bittner M; Yakhini Z; Kaminski N
Lung Cancer; 2007 May; 56(2):175-84. PubMed ID: 17258348
[TBL] [Abstract][Full Text] [Related]
15. Predicting response to chemotherapy with early-stage lung cancer.
Rosell R; Taron M; Massuti B; Mederos N; Magri I; Santarpia M; Sanchez JM
Cancer J; 2011; 17(1):49-56. PubMed ID: 21263267
[TBL] [Abstract][Full Text] [Related]
16. Landscape of somatic allelic imbalances and copy number alterations in human lung carcinoma.
Staaf J; Isaksson S; Karlsson A; Jönsson M; Johansson L; Jönsson P; Botling J; Micke P; Baldetorp B; Planck M
Int J Cancer; 2013 May; 132(9):2020-31. PubMed ID: 23023297
[TBL] [Abstract][Full Text] [Related]
17. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
[TBL] [Abstract][Full Text] [Related]
18. Gene expression signature predicts recurrence in lung adenocarcinoma.
Larsen JE; Pavey SJ; Passmore LH; Bowman RV; Hayward NK; Fong KM
Clin Cancer Res; 2007 May; 13(10):2946-54. PubMed ID: 17504995
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal aberrations in Korean nonsmall cell lung carcinomas: degenerate oligonucleotide primed polymerase chain reaction comparative genomic hybridization studies.
Park SY; Kim YH; In KH; Chun YH; Park SH
Cancer Genet Cytogenet; 2004 Jul; 152(2):153-7. PubMed ID: 15262437
[TBL] [Abstract][Full Text] [Related]
20. Tumor transcriptome reveals the predictive and prognostic impact of lysosomal protease inhibitors in non-small-cell lung cancer.
Petty RD; Kerr KM; Murray GI; Nicolson MC; Rooney PH; Bissett D; Collie-Duguid ES
J Clin Oncol; 2006 Apr; 24(11):1729-44. PubMed ID: 16549823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
